Table 1.
aCGH platform | No. of probes at ESR1 locus |
Breast tumors | ER status | |||
---|---|---|---|---|---|---|
N | Gains (%) | Amplification (%) | ER+ (%) | ER− (%) | ||
Oligo aCGH2 | 4 | 171 | 13 (8) | 2 (1) | 113 (66) | 58 (34) |
BAC aCGH4 | 1 | 143 | 5 (3) | 0 (0) | 94 (66) | 49 (34) |
Agilent 244K aCGH | 33 | 77 | 7 (9) | 2 (3) | 75 (97) | 2 (3) |